National Cancer Institute head named acting FDA commissioner
FDA Commissioner Scott Gottlieb said last Tuesday that he’s planning to resign in a few weeks.
FDA
What’s next for FDA? Four areas where the agency will have to fill a Gottlieb-sized void
What’s waiting on the desk of the next FDA commissioner.
Reports: Gottlieb to resign from FDA
Gottlieb has served in the FDA’s top job since April 2017.
4 healthcare things to know about the new federal budget
#1: The FDA is getting its biggest funding increase since 2010.
CHC’s Jon Bigelow: Pharma marketers need to ‘state our value’ to Washington
Coalition for Healthcare Communication executive director Jon Bigelow identified issues to watch in Washington for pharma marketers at an MM&M event on Tuesday.
Watch: Juul debuts first TV ad campaign
In the Make the Switch push, the company is using testimonials from people who say Juul e-cigarettes helped them quit smoking.
These 5 companies have the most at stake if drug prices are based on international averages
The Trump administration has proposed basing Medicare Part B drug prices on what other countries pay.
FDA turns attention to vapes in latest version of Real Cost anti-tobacco campaign
An estimated 10.7 million teens are vaping or thinking about it.
With a nod from the FDA, Teva enters white-hot migraine market
Teva’s Ajovy becomes the second approved CGRP migraine therapy, following Amgen’s Aimovig.
Five things for pharma marketers to know: Wednesday, September 12, 2018
FDA threatens to ban flavored vapes; Cigna launches $250 million venture fund; Takeda shutters Chicago operations.
